Clinical Trial Update: Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

A trial update on an oral vitamin D and Toll-like receptor approach for spondylitis tuberculosis in Phase 2 and Phase 3 is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spondylitis
• Tuberculosis

Drugs mentioned

• Toll Like Receptor (Toll-like receptor)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Hasanuddin University | Conditions: Spondylitis, Tuberculosis | Phase 2, Phase 3 | Status: UNKNOWN